UNSPSC 85813821: Introduction of destructive agent into joints, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of destructive agent into joints, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0U3TZ

UNSPSC 85813821 Introduction of destructive agent into joints, percutaneous approach is a Commodity code that shows little relevant recent activity in state and local procurement. The recent opportunities tagged under this code reflect healthcare service procurement across multiple domains — virtual urgent care, occupational health, behavioral health, opioid treatment, emergency medical services, cancer screening, and medical director services — none of which align with the code's nominal scope of joint-injection procedures. The code appears to be either misapplied by issuing bodies or substantially underutilized in state and local contracting.

The available records span multiple issuing bodies and geographies with no meaningful pattern tied to the code's stated purpose. Opportunities originated from California health plans, Georgia counties, Nevada state authorities, Colorado state agencies, Florida jurisdictions, Illinois state offices, Texas entities, Kansas counties, Missouri counties, and others across a scattered national footprint. Representative recent solicitations include the Nevada Health Authority's RFP for Program of All Inclusive Care for the Elderly (proposals due December 10, 2026) and the Colorado Department of Human Services' request for nursing home placement beds (proposals due September 10, 2026). Neither procurement involves destructive-agent joint procedures; both concern broader healthcare service delivery and facility operations. Without alignment between the code designation and the actual work being procured, this code does not signal a viable market opportunity for specialists in joint-injection services at the state and local level.